Clin2
NCT04873011Possibly a fitRecruiting

Quinine in overweight women to change hunger and gut hormones

Obesity

Part of Hormones & metabolism clinical trials.

This early study tests whether quinine affects hunger and digestion-related gut hormones in women who are mildly overweight. It may help researchers understand how the body controls appetite, but it is mainly to check effects and safety.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
40 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be a woman age 18 to 65
  • Your BMI must be between 25 and 30, and your weight should be stable for at least 3 months
  • If you could become pregnant, you must use very reliable birth control during the whole study
  • You must agree to participate and sign consent after understanding the procedures
  • You should NOT be pregnant or breastfeeding, and you should not be currently trying to lose weight
  • You must not have certain stomach/medical/mental conditions or medication that could change digestion or blood sugar

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07508020Recruiting· Phase 1
How a new medicine affects appetite and metabolism in people with obesity

This study tests an experimental drug (NNC0487-0111) to see how it changes food intake, appetite, and the way your body processes food after meals. It is for adults with obesity who do not have diabetes.

Berlin
NCT06174389Recruiting
Weight loss study: diet, appetite and body changes

This study looks at how diet, appetite, and body changes work together during weight loss. It's designed for people with a BMI of 30 to 50 who want to lose weight and are not taking certain medications or have certain health conditions.

Seattle, Washington
NCT07793019Not yet recruiting· Phase 1
Weight loss and safety study in overweight adults

This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.

Beijing, Beijing Municipality
NCT03024879Enrolling by invitation· Phase 4
Testing how motilin affects appetite and food intake frequency

This trial tests whether motilin changes how often and how much people eat. It likely helps researchers understand appetite control, which can be relevant for weight and digestive health.

NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas
NCT07715955Recruiting
Can probiotics help control appetite in adults with overweight or obesity?

This study tests whether taking probiotics can help regulate appetite in people who are overweight or have obesity. It aims to understand if these supplements can support weight management by affecting hunger and fullness signals.

Maastricht, Limburg

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.